Published • loading... • Updated
Sleep apnea pill maker Apnimed files for US IPO as biotech market revives - Regional Media News
Summary by regionalmedianews.com
1 Articles
1 Articles
Sleep apnea pill maker Apnimed files for US IPO as biotech market revives - Regional Media News
July 10 (Reuters) - Apnimed, a late-stage clinical pharmaceutical company, filed for an initial public offering in the U.S. on Friday. The biotech sector has staged a notable comeback as fresh capital flows back into the industry, improving market sentiment after a prolonged downturn. Initial public offerings in the biotech sector plunged to their lowest level in more than a decade in 2025. Founded in 2017, Apnimed is a clinical-stage company fo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
